Vgi Partners Pty LTD Has Cut Amazon Com (AMZN) Position By $3.90 Million; Pacira Pharmaceuticals Has 0.93 Sentiment

June 14, 2018 - By Richard Conner, Inc. (NASDAQ:AMZN) Logo

Pacira Pharmaceuticals Inc (PCRX) investors sentiment decreased to 0.93 in Q1 2018. It’s down -0.47, from 1.4 in 2017Q4. The ratio is negative, as 77 investment managers increased and opened new stock positions, while 83 cut down and sold positions in Pacira Pharmaceuticals Inc. The investment managers in our database now own: 41.78 million shares, up from 40.06 million shares in 2017Q4. Also, the number of investment managers holding Pacira Pharmaceuticals Inc in top ten stock positions decreased from 4 to 2 for a decrease of 2. Sold All: 32 Reduced: 51 Increased: 49 New Position: 28.

Vgi Partners Pty Ltd decreased Amazon Com Inc (AMZN) stake by 3.21% reported in 2018Q1 SEC filing. Vgi Partners Pty Ltd sold 2,694 shares as Amazon Com Inc (AMZN)’s stock rose 5.80%. The Vgi Partners Pty Ltd holds 81,171 shares with $117.48 million value, down from 83,865 last quarter. Amazon Com Inc now has $836.46B valuation. The stock increased 1.11% or $19 during the last trading session, reaching $1723.86. About 3.14 million shares traded., Inc. (NASDAQ:AMZN) has risen 62.09% since June 14, 2017 and is uptrending. It has outperformed by 49.52% the S&P500. Some Historical AMZN News: ; 18/05/2018 – Watch out, Sephora and Ulta: Amazon is coming for higher-end beauty shoppers. Via @Racked:; 15/03/2018 – Some companies with learning management software, like Workday, pay Amazon Web Services for cloud computing resources; 26/04/2018 – NBC DFW: #BREAKING – Amazon to increase price of annual Prime membership May 11:; 27/04/2018 – Nutanix’s Amazon Cloud Killer Delayed by Engineering Problems; 16/04/2018 – Fnac Darty strengthens ties with Google in bid to tackle Amazon; 03/04/2018 – Conor Sen: @selling_theta *NO ONGOING WHITE HOUSE TALKS ABOUT ACTION ON AMAZON; 26/04/2018 – Amazon’s AWS and advertising businesses are fueling its retail dominance High growth plus big margins equals trouble for all other retailers; 05/04/2018 – TRUMP SAYS AMAZON DOES NOT USE A LEVEL PLAYING FIELD, IT HAS TO BE LEVEL FOR EVERYONE; 10/04/2018 – Matt Rosoff: Exclusive from @levynews: GOP Senator is moving to close the cheap shipping loophole that helps Chinese businesses; 20/03/2018 – Amazon elbows Alphabet aside as second most valuable company

Since February 15, 2018, it had 0 buys, and 21 sales for $63.19 million activity. Shares for $2.99M were sold by WILKE JEFFREY A. $2.17 million worth of stock was sold by STONESIFER PATRICIA Q on Wednesday, May 2. Another trade for 1,985 shares valued at $2.90 million was made by Jassy Andrew R on Thursday, February 15. Blackburn Jeffrey M also sold $3.23M worth of, Inc. (NASDAQ:AMZN) shares. $795,502 worth of, Inc. (NASDAQ:AMZN) shares were sold by Reynolds Shelley. 1,927 shares were sold by Zapolsky David, worth $3.03 million on Tuesday, May 15. $1.01M worth of stock was sold by ALBERG TOM A on Wednesday, February 21.

More notable recent, Inc. (NASDAQ:AMZN) news were published by: which released: “Microsoft takes aim at Amazon Go” on June 14, 2018, also with their article: “Amazon makes a beauty move in Brazil” published on June 14, 2018, published: “Seattle council repeals ‘head tax'” on June 13, 2018. More interesting news about, Inc. (NASDAQ:AMZN) were released by: and their article: “6 Most Important Things In Business Today” published on June 14, 2018 as well as‘s news article titled: “Microsoft Corporation and Cloud Kings Become Chip Giants” with publication date: June 13, 2018.

Investors sentiment decreased to 1.08 in Q1 2018. Its down 0.21, from 1.29 in 2017Q4. It fall, as 73 investors sold AMZN shares while 659 reduced holdings. 173 funds opened positions while 614 raised stakes. 266.38 million shares or 4.87% less from 280.02 million shares in 2017Q4 were reported. Sfe Inv Counsel reported 1.57% in, Inc. (NASDAQ:AMZN). C V Starr & holds 10.32% or 1,500 shares. Wisconsin-based Schaper Benz Wise Counsel Wi has invested 0.21% in, Inc. (NASDAQ:AMZN). 10,640 were accumulated by Omega Advsr Inc. Douglass Winthrop Advsrs Ltd Liability Corp has invested 0.38% in, Inc. (NASDAQ:AMZN). Meritage Group Inc Limited Partnership holds 4.87% or 193,173 shares in its portfolio. 429 are owned by Sabal Trust Com. National Pension accumulated 337,253 shares. Bancorp Hapoalim Bm, a Israel-based fund reported 4,036 shares. First Pacific Advsr Limited Liability stated it has 0.01% in, Inc. (NASDAQ:AMZN). Fcg Advsrs invested in 700 shares or 0.35% of the stock. Westfield Capital Mgmt Ltd Partnership stated it has 2.53% of its portfolio in, Inc. (NASDAQ:AMZN). Vantage Investment Prtn Ltd owns 13,342 shares. Rmb Cap Mngmt Ltd Company stated it has 5,479 shares. Private Ocean Llc has 717 shares for 0.49% of their portfolio.

Analysts await, Inc. (NASDAQ:AMZN) to report earnings on July, 26. They expect $2.52 EPS, up 530.00% or $2.12 from last year’s $0.4 per share. AMZN’s profit will be $1.22B for 171.02 P/E if the $2.52 EPS becomes a reality. After $3.27 actual EPS reported by, Inc. for the previous quarter, Wall Street now forecasts -22.94% negative EPS growth.

Among 55 analysts covering (NASDAQ:AMZN), 52 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. had 304 analyst reports since July 21, 2015 according to SRatingsIntel. Monness reinitiated the stock with “Buy” rating in Wednesday, April 11 report. On Tuesday, September 27 the stock rating was maintained by JP Morgan with “Overweight”. Susquehanna initiated, Inc. (NASDAQ:AMZN) on Monday, January 18 with “Positive” rating. As per Monday, October 24, the company rating was maintained by Goldman Sachs. On Friday, October 23 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm earned “Buy” rating on Friday, January 29 by UBS. The stock has “Buy” rating by Robert W. Baird on Friday, April 27. The company was maintained on Monday, January 8 by Credit Suisse. On Tuesday, May 3 the stock rating was maintained by Nomura with “Buy”. The stock of, Inc. (NASDAQ:AMZN) earned “Buy” rating by UBS on Monday, July 17.

Vgi Partners Pty Ltd increased Coca Cola Co (NYSE:KO) stake by 378,479 shares to 1.65M valued at $71.45M in 2018Q1. It also upped Colgate Palmolive Co (NYSE:CL) stake by 295,718 shares and now owns 1.13 million shares. Cme Group Inc (NASDAQ:CME) was raised too.

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, makes, and commercializes proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers in the United States. The company has market cap of $1.57 billion. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. It currently has negative earnings. The companyÂ’s lead product includes, EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia.

The stock increased 0.26% or $0.1 during the last trading session, reaching $38.45. About 527,929 shares traded. Pacira Pharmaceuticals, Inc. (PCRX) has declined 23.22% since June 14, 2017 and is downtrending. It has underperformed by 35.79% the S&P500. Some Historical PCRX News: ; 06/04/2018 – Pacira Pharmaceuticals Plans Conference Call Monday Morning; 03/05/2018 – PACIRA 1Q ADJ EPS 2C, EST. 2C; 06/04/2018 – Pacira Confirms FDA Approval of Supplemental New Drug Application for Exparel as Nerve Block to Produce Regional Analgesia; 10/04/2018 – PACIRA PHARMACEUTICALS INC PCRX.O : JP MORGAN RAISES TARGET PRICE TO $43 FROM $40; 06/04/2018 – PACIRA: FDA OKS EXPAREL AS NERVE BLOCK TO PRODUCE REG ANALGESIA; 06/04/2018 – Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® as a Nerve Block to Produce Regional Analgesia; 06/04/2018 – $PCRX Here is the full Pacira Pharma Exparel label; 09/04/2018 – PACIRA PHARMACEUTICALS INC PCRX.O : BMO RAISES TARGET PRICE TO $34 FROM $31; 06/04/2018 – $PCRX approved. Narrow label for brachial plexus block; 06/04/2018 – PACIRA PARES GAIN AFTER FDA REMOVES EXPAREL UPDATE FROM WEBSITE

Since January 1, 0001, it had 0 insider buys, and 9 sales for $2.87 million activity.

Analysts await Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) to report earnings on August, 1. They expect $-0.16 earnings per share, up 44.83% or $0.13 from last year’s $-0.29 per share. After $-0.18 actual earnings per share reported by Pacira Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -11.11% EPS growth.

Ratings analysis reveals 71% of Pacira Pharma’s analysts are positive. Out of 7 Wall Street analysts rating Pacira Pharma, 5 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. The lowest target is $34.0 while the high is $93.0. The stock’s average target of $54.83 is 42.60% above today’s ($38.45) share price. PCRX was included in 7 notes of analysts from October 19, 2016. Canaccord Genuity initiated it with “Buy” rating and $55.0 target in Wednesday, February 22 report. The rating was maintained by Wedbush with “Outperform” on Wednesday, October 19. The rating was maintained by Mizuho on Thursday, November 3 with “Buy”. H.C. Wainwright initiated the stock with “Buy” rating in Tuesday, January 3 report. As per Friday, December 30, the company rating was maintained by Janney Capital. Goldman Sachs initiated Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Thursday, December 1 with “Neutral” rating. The stock of Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has “Outperform” rating given on Thursday, April 13 by RBC Capital Markets.

Consonance Capital Management Lp holds 7.5% of its portfolio in Pacira Pharmaceuticals, Inc. for 2.63 million shares. Venbio Select Advisor Llc owns 1.72 million shares or 2.55% of their US portfolio. Moreover, Healthcor Management L.P. has 2.44% invested in the company for 2.30 million shares. The New York-based Daruma Capital Management Llc has invested 2.21% in the stock. Elk Creek Partners Llc, a Colorado-based fund reported 1.00 million shares., Inc. (NASDAQ:AMZN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Richard Conner

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts